Crossmark

Generation of an Induced Pluripotent Stem Cell Line ERCi003-A Derived from a Patient with Maturity-Onset Diabetes of the Young Type 10 Caused by a Heterozygous INS Mutation

Crossref DOI link: https://doi.org/10.1134/S106236042470019X

Published Online: 2025-02-28

Published Print: 2024-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bastrich, A. N.

Antonov, D.

Podzhilkova, A.

Petrova, D. A.

Pylina, S. V.

Laptev, D. N.

Sechko, E. A.

Kuznetsov, S. N.

Vetchinkina, E. A.

Mokrysheva, N. G.
License Information

Text and Data Mining valid from 2024-08-01

Version of Record valid from 2024-08-01
More Information

Article History

Received: 15 August 2024

Revised: 10 October 2024

Accepted: 12 November 2024

First Online: 28 February 2025

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

: The study was approved by the Ethics Committee of Endocrinology Research Centre, Moscow, Russia, Protocol no. 13 of July 12, 2023. The patient was provided with all information about this study and signed an informed consent and an information sheet with his own hand.

: The authors of this work declare that they have no conflicts of interest.

Document is current

Any future updates will be listed below